WO2005016425A1 - Interface nasale et systeme comprenant un element d'insertion de ventilation - Google Patents

Interface nasale et systeme comprenant un element d'insertion de ventilation Download PDF

Info

Publication number
WO2005016425A1
WO2005016425A1 PCT/US2003/024590 US0324590W WO2005016425A1 WO 2005016425 A1 WO2005016425 A1 WO 2005016425A1 US 0324590 W US0324590 W US 0324590W WO 2005016425 A1 WO2005016425 A1 WO 2005016425A1
Authority
WO
WIPO (PCT)
Prior art keywords
flow passage
gas flow
ventilation interface
ventilation
interface according
Prior art date
Application number
PCT/US2003/024590
Other languages
English (en)
Inventor
Thomas J. Wood
Bruce Sher
Shara Hernendez
Original Assignee
Innomed Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innomed Technologies, Inc. filed Critical Innomed Technologies, Inc.
Priority to AU2003258103A priority Critical patent/AU2003258103A1/en
Priority to PCT/US2003/024590 priority patent/WO2005016425A1/fr
Priority to US10/876,480 priority patent/US7000613B2/en
Priority to US10/880,521 priority patent/US7472707B2/en
Publication of WO2005016425A1 publication Critical patent/WO2005016425A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0683—Holding devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0666—Nasal cannulas or tubing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816—Joints or connectors
    • A61M16/0833—T- or Y-type connectors, e.g. Y-piece
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816—Joints or connectors

Definitions

  • Exemplary embodiments of the invention are directed to a ventilation interface, and more particularly to a ventilation interface including a cannula forming a first portion of an input gas flow passage and a nasal insert forming a second portion of the input gas flow passage, the first and second portions of the input gas flow passage disposed at an obtuse angle to one another.
  • Obstructive sleep apnea syndrome (commonly referred to as obstructive sleep apnea, sleep apnea syndrome, and/or sleep apnea) is a medical condition characterized by repeated, prolonged episodes of cessation of breathing during sleep.
  • the muscles of the upper part of the throat passage of an individual keep the passage open, thereby permitting an adequate amount of oxygen to flow into the lungs.
  • the throat passage is narrowed due to the relaxation of the muscles. In those individuals having a relatively normally sized throat passage, the narrowed throat passage remains open enough to continue to permit the adequate amount of oxygen to flow into the lungs.
  • the narrowed throat passage prohibits the adequate amount of oxygen from flowing into the lungs.
  • one or more of a nasal obstruction, a relatively large tongue, and/or certain shapes of the palate and/or the jaw of the individual further prohibit the adequate amount of oxygen from flowing into the lungs.
  • the individual having the above-discussed conditions can stop breathing for one or more prolonged periods of time (e.g., each period of time being 10 seconds or more).
  • the prolonged periods of time during which breathing is stopped, or apneas are generally followed by sudden reflexive attempts to breathe.
  • the reflexive attempts to breathe are generally accompanied by a change from a relatively deeper stage of sleep to a relatively lighter stage of sleep.
  • the individual suffering from obstructive sleep apnea syndrome generally experiences fragmented sleep that is not restful.
  • the fragmented sleep results in one or more of excessive and/or inappropriate daytime drowsiness, headache, weight gain or loss, limited attention span, memory loss, poor judgment, personality changes, lethargy, inability to maintain concentration, and/or depression.
  • Other medical conditions can also prevent individuals, including adults and infants, from receiving the adequate amount of oxygen into the lungs. For example, an infant who is born prematurely can have lungs that are not developed to an extent necessary to receive the adequate amount of oxygen. Further, prior to, during, and/or subsequent to certain medical procedures and/or medical treatments, an individual can be unable to receive the adequate amount of oxygen.
  • a ventilation interface to apply a positive pressure to the throat of the individual, thereby permitting the adequate amount of oxygen to flow into the lungs.
  • oxygen and/or room air containing oxygen is delivered through the mouth and/or nose of the individual.
  • CPAP continuous positive airway pressure
  • BiPAP bilevel positive airway pressure
  • IPPV intermittent mechanical positive pressure ventilation
  • a known ventilation interface for the application of such positive pressures includes a conventional face mask that covers the nose and/or mouth, as well as a conventional pair of nasal pillows that are inserted into corresponding nares of the naris.
  • the conventional face mask requires a harness, such as a headband and/or other headgear components, to provide and maintain a required fluid or gas tight seal between the mask and the face of the individual. Additionally, the conventional tubing will collapse if it is bent around the ears with the flat side against the side of the users head.
  • a conventional harness and tubing results in a number of disadvantages. For example, because pressure must be applied between the required harness and the head of the individual to maintain the required seal, the harness is generally uncomfortable, particularly when sleeping. The applied pressure often results in undesirable irritation and sores caused by movement of the mask and harness during periods of both wakefulness and sleep. Further, the required seal is generally unable to be maintained when the mask and harness is moved.
  • the mask also generally applies an undesirable pressure to the sinus area that is adjacent to the nose, causing the nasal sinus airways to narrow, thereby increasing a velocity of flow through the upper anatomical airways and decreasing lateral pressure against the nasal mucosal walls.
  • the tubing may fold, undesirably further exacerbating the above problem.
  • the above-discussed combination of increased flow velocity and decreased pressure results in the removal of moisture from the mucosal walls during inspiration, causing an undesirable drying and a burning sensation within the nares.
  • the individual may remove the mask to alleviate these discomforts, consequently discontinuing the beneficial application of the positive pressure.
  • the conventional nasal pillows include pillowed style nasal seals that are pressed against the bottom portion of the nares.
  • the known nasal pillows also require the use of a harness to keep the nasal pillows pressed against the bottom of the nares, resulting in disadvantages similar to those of the conventional face mask. For these reasons, it is desirable to provide a nasal interface and system that overcomes one or more of the above-discussed disadvantages.
  • Exemplary embodiments of the present invention provide a ventilation interface adapted to be inserted into a nares of a user to secure the interface.
  • a cannula adapted to be connected to a source of ventilation gas forms a first portion of an input gas flow passage to supply the ventilation gas to the user.
  • a nasal insert adapted to be inserted into the nares of the user forms a second portion of the input gas flow passage from the cannula to a distal end of the nasal insert.
  • a seal portion adapted to engage a portion of the first nares can be provided adjacent the distal end of the nasal insert.
  • the first and second portions of the input gas flow passage are disposed at an obtuse angle to one another.
  • a gas output forms a portion of an output gas flow passage from the nasal insert to an exterior of the ventilation interface to channel a gas expired by the user.
  • the second portion of the input gas flow passage and the portion of the output gas flow passage can be configured to provide laminar flow therebetween.
  • the seal portion of the nasal insert forms a seal with the naris of the user by optionally a resiliency of the seal portion of the nasal insert or a resiliency of the nares of the user or some combination of the two.
  • at least one of the nasal insert and the seal portion may, optionally, be sufficiently flexible to be expanded by a positive pressure provided by the ventilation gas to help form a seal portion.
  • Exemplary embodiments of the present invention further provide a ventilation interface adapted to be inserted into a nares of a user which can secure the interface.
  • a first subassembly forms a first portion of an input gas flow passage from a ventilation gas supply source.
  • a second subassembly forms a second portion of the input gas flow passage from the first subassembly to a first naris of the nares of the user.
  • a subassembly for engaging a portion of the first naris is provided on the second subassembly.
  • the first and second portions of the input gas flow passage are disposed at an obtuse angle to one another.
  • Exemplary embodiments of the present invention further provide a feed tube and y-connector adapted for use in a ventilation interface system.
  • the feed tube having an annular sleeve and may optionally include a first exterior portion and a second exterior portion; the first exterior portion including a plurality of first ribs and a second exterior portion including a plurality of second ribs.
  • Yet further exemplary embodiments of the present invention provide a ventilation interface system including a cannula adapted to be connected to a source of ventilation gas via a feed tube and a y-connector, the cannula forming a first portion of an input gas flow passage to supply the ventilation gas to the user.
  • a nasal insert adapted to be inserted the nares of the user, the nasal insert forming a second portion of the input gas flow passage from the cannula to a distal end of the nasal insert.
  • a seal portion adapted to engage at least a portion of the nares of the user, the seal portion provided adjacent the distal end of the nasal insert wherein the first and second portions of the input gas flow passage are disposed at an obtuse angle to one another.
  • head or harness gear may provided to assist holding the nasal inserts gently in place.
  • Figure 1 shows an exploded side elevation view of a first exemplary embodiment of the ventilation interface system.
  • Figure 2 shows a side elevation view of a ventilation insert.
  • Figure 3 shows a side view of the ventilation insert of Figure 2.
  • Figure 4 shows a top view of the ventilation insert of Figure 2.
  • Figure 5 shows a side view of the ventilation insert of Figure 2.
  • Figure 6 shows a cross-sectional view taken from line V-V in Figure 3.
  • Figure 7 shows an elevated side view of an oval feed tube.
  • Figure 8 shows a cross-section of an oval end of the feed tube.
  • Figure 9 shows a cross-sectional view of the oval feed tube of Figure 7.
  • Figure 9 shows a side view of a round feed tube.
  • Figure 10 shows a side view of a round feed tube.
  • Figure 11 shows a cross-section of the round feed tube of Figure 10.
  • Figure 12 shows a cross-sectional view of the round feed tube of figure 9.
  • the present invention can provide a ventilation interface system adapted to be inserted into a nares of a user to secure the interface.
  • a cannula 300 adaptable to be connected to a source of ventilation gas (not shown) forms a first portion 141 of an input gas flow passage to supply the ventilation gas to the user.
  • Nasal inserts 120 are adapted to be inserted into the nares of the user forms a second portion 123 of the input gas flow passage from the cannula to a distal end of the nasal insert 130.
  • a seal portion 122 optionally adapted to engage a portion of the nares of the user is positioned at the distal end 130 of the nasal insert.
  • the first 141 and second portions 123 of the input gas flow passage are disposed at an obtuse angle to one another. In another exemplary embodiment of the invention, the obtuse angle is between about 110° and about 170°, and more preferably the obtuse angle is about 135°.
  • gas output flow passages 150 form a portion of an output gas flow passage from the nasal insert 120 to an exterior of the ventilation interface to channel a gas expired by the user.
  • the second portion 123 of the input gas flow passage formed by the nasal insert is about parallel with the portion of the output gas flow passage 150.
  • the second portion 123 of the input gas flow passage and the portion of the output gas flow passage 150 are configured to, optionally, provide laminar flow therebetween.
  • the nasal inserts 120, and the seal portions 122 form a seal with the nares of the user by, optionally, a resiliency of the seal portion 122 and nasal insert 120 or a resiliency of the nares of the user or some combination of the above with a headgear 700 assisting in gently holding the nasal insert 120 into the nares.
  • at least one of the nasal inserts 120 and the seal portions 122 may, optionally, be sufficiently flexible to be expanded by a positive pressure provided by the ventilation gas to help form a seal with the nares of the user.
  • exemplary embodiments of a ventilation interface 100 of the present invention can include, among other components, a cannula 300, nasal inserts 120, seal portions 122 and gas outputs 150, to be described below.
  • the cannula 300 can be adapted to be connected to a source of ventilation gas (not shown), such as oxygen and/or room air containing oxygen, to apply a positive pressure to the throat of the user of the ventilation interface 100, thereby permitting an adequate amount of oxygen to flow into the lungs.
  • a source of ventilation gas such as oxygen and/or room air containing oxygen
  • the system may be connected to a mechanical ventilator.
  • the cannula 300 can be of any type, so long as the cannula 300 can be connected to the source of the ventilation gas.
  • the cannula 300 can includes a distal end 142 connectable to the source of the ventilation gas via a feed tube 500, 600.
  • the y-connector 703 can include an exterior surface and an interior surface defining a wall portion therebetween, each of the exterior and interior surfaces having optionally substantially circular or ovalular cross section. By this arrangement, the y- connector 703 can be connected with the source of the ventilation gas at one end and to the feed tube at the other end 500, 600.
  • the cannula 300 can include a cannula body 303 adjacent to distal end 142 that defines a first portion 141 of the input gas flow passage, and more specifically can define the second portion 123 of the input gas flow passage through the cannula body 303.
  • the cannula body 303 can define a portion of an output gas flow passage, and, more specifically, can define the fourth portion 153 of the output gas flow passage from the nasal insert 120 through the cannula body 303 (discussed below).
  • the cannula body 303 can extend along one or more axes such that laminar flow can be achieved within the second portion 123 of the input gas flow passage and/or such that laminar flow can be achieved within the fourth portion 153 of the output gas flow passage.
  • the cannula body 303 can extend along the one or more axes such that laminar flow can be achieved between the second portion 123 of the input gas flow passage and portions of the input gas flow passage upstream and/or downstream of the second portion, and/or can extend along the one or more axes such that laminar flow can be achieved between the fourth portions 153 and the second portions 123 of the output gas flow passage.
  • portions of the axes of the second portion 123 of the input gas flow passage and/or the fourth portion 153 of the output gas flow passage extend along a substantially arcuate line.
  • the nasal insert 120 can be disposed adjacent the cannula body 303 and can be adapted to be inserted the nares of the user to apply the positive pressure to the throat of the user.
  • the nasal insert 120 can be of any type, so long the nasal insert 120 can be inserted into the nares to apply the positive pressure.
  • the nasal insert 120 can define a third portion 305 and a fourth portion 153 of the input gas flow passage, and more specifically can define the third 305 and fourth 153 portions of the input gas flow passage from the cannula 300 through the nasal insert 120.
  • the nasal insert 120 can define a second portion 123 and a third portion 305 of the output gas flow passage, and more specifically can define the second 123 and third 305 portions of the output gas flow passage from the sealing portion 122 through the nasal insert 120.
  • the nasal insert 120 can include an exterior surface and an interior surface defining a wall portion therebetween, each of the exterior and interior surfaces may have a varying cross section including oval shapes or, optionally, substantially circular or flat shapes, such that the nasal inserts 120 can define the above-identified flow passages.
  • the nasal insert 120 can have a maximum interior cross sectional area and circumference at a proximal end 121 of the nasal insert 120 that is adjacent the cannula 300, thereby defining the third portion 305 of the input/output gas flow passage.
  • the nasal insert 120 may optionally have a minimal interior cross sectional area and circumference at a distal end 130 of the nasal insert 120 that is disposed away from the cannula 300 (i.e., opposite the proximal end 121), thereby defining the fourth portion 153 of the input/output gas flow passage, and thereby defining the second portion 123 of the input/output gas flow passage.
  • the nasal insert 120 may have the substantially same interior cross sectional area and circumference at the distal 130 and proximal ends 121.
  • the proximal end 121 may, optionally, be in the form of an ellipse or circle and the distal end 122 can be in the form of an ellipse or circle.
  • the nasal insert 120 can extend along an axis such that laminar flow can be achieved within and/or between the third 305 and fourth portions 153 of the input/output gas flow passage, and/or within and/or between the second 123 and third 305 portions of the output gas flow passage. Further, the nasal insert 120 can extend along the axis such that laminar flow can be achieved among the third 305 and fourth 153 portions of the input/output gas flow passage and portions of the input gas flow passage upstream and/or downstream of the third 305 and fourth 153 portions, and/or such that laminar flow can be achieved among the second and third portions of the output gas flow passage and portions of the output gas flow passage upstream and/or downstream of the second 123 and third 305 portions.
  • the seal portion 122 can be disposed adjacent the distal end 130 of the nasal insert 120, and can be adapted to engage the interior portion of the user's nares to thereby retain the ventilation interface 100 therewithin.
  • the seal portion 122 can be of any type, so long as the seal portion 122 can engage the interior portion of the nares.
  • the seal portion 122 can include an exterior surface and an interior surface defining a wall portion therebetween, each of the exterior and interior surfaces may have an about C-shaped or arcuate surface and having a circular or oval cross section, such that the seal portion 122 can define the above-identified flow passages.
  • An interior portion of the seal portion 122 can have an interior cross section in the form of an ellipse, or alternatively can have one or both of an interior surface and an exterior surface with an about tear-shaped or optionally a circular cross-section.
  • the maximum interior cross section and its corresponding circumference may, optionally, be greater than the interior cross section and circumference of the distal end 130 of the nasal insert 120.
  • a maximum exterior cross section and its corresponding circumference of the seal portion 122 may optionally be greater than the exterior cross section and circumference of the distal end 130.
  • the seal portion 122 and/or the nasal insert 120 can include an elastic material, the resiliency of which may retain the first ventilation interface 100 in the nares.
  • the seal portion 122 and/or the nasal insert 120 can optionally be expanded by the positive pressure of the ventilation gas, thereby aiding in the retention of the first ventilation interface 100 within the nares.
  • the nasal insert 120 need not deform when entering the user's nares.
  • the seal portion 122 can extend along an axis such that laminar flow can be achieved within the fifth portion 152 of the input gas flow passage, and/or within the first portion of the output gas flow passage.
  • the seal portion 122 can extend along the axis such that laminar flow can be achieved between the fifth 152 portion of the input gas flow passage and upstream of the input gas flow passage, and/or such that laminar flow can be achieved between the first 141 portion of the output gas flow passage and downstream of the output gas flow passage.
  • the axis is substantially a straight line.
  • the gas output 150 can be disposed adjacent the cannula body 303 opposite to the nasal insert 120, and can be adapted to channel the gas expired by the user to the exterior of the ventilation interface. Although the figures show certain exemplary embodiments of the gas output 150, it is to be understood that the gas output 150 can be of any type, so long as the gas output 150 can channel the gas expired by the user to an exterior of the ventilation interface 100.
  • the gas output 150 can define a fifth portion 152 of the output gas flow passage, and more specifically can define the fifth 152 of the output gas flow passage from the cannula body 303 through the gas output.
  • the gas output 150 can include an exterior surface and an interior surface defining a wall portion therebetween, each of the exterior and interior surfaces having a varying cross section including circular shapes, such that the gas output 150 can define the above-identified flow passages.
  • the gas output 150 can have a maximum interior cross sectional area and circumference at a proximal end 141 of the gas output 150 that is adjacent the cannula body 303, thereby defining the fifth 152 portion of the output gas flow passage.
  • the gas output 150 can have a minimal interior cross sectional area and circumference at a distal end 157 of the gas output 150 that is disposed away from the cannula body 303 (i.e., opposite the proximal end 141), thereby defining the fifth 152 portion of the output gas flow passage.
  • laminar flow is achieved among and/or within one or more of the portions (i.e., the first through fifth portions) of the input gas flow passage of the first ventilation interface 100 of the ventilation interface 100, and more preferably is achieved among and within all of the portions of the input gas flow passage.
  • the output gas flow passage can channel the expired gas from the nares of the user of the ventilation interface 100, and more specifically can channel the expired gas from of the nares of the user to and through the first portion of the sealing portion 122, to and through the third 305 portion of the distal end 122 of the nasal insert 120, to and through the second 123 portion of the proximal end 121 of the nasal insert 120, to and through the fourth 153 portion of the cannula body 303 of the cannula 300, to and through the fifth 152 portion of the gas output 150, to the exterior of the ventilation interface 100.
  • laminar flow is achieved among and/or within each of the portions (i.e., the first through fifth portions) of the output gas flow passage of the ventilation interface 100, and more optionally is achieved among and within all the portions of the output gas flow passage.
  • a ventilation interface 100 according to exemplary embodiments of the present invention can avoid disadvantages of the known or conventional ventilation interface requiring a harness. Referring generally to figures 7-12.
  • the oval feed tubing 500 provides an oval cross-section 505.
  • the distance 503 between the ribs 501 at the bottom surface shorten when bent and the distance between the ribs 504 on the top 502 surface of the tubing wall lengthens in order for the tubing to bend without decreasing the cross-sectional area of the tube.
  • This also gives the oval tubing 500 the ability to drape around the ears of a user.
  • circular tubing 600, with a circular cross-sectional are 602, provides ribs 601 which can be bent around the ears.
  • the distance between the bottom ribs 503 are spaced when the tubing is straight. When draped in a radius position the distance between the lower ribs 503 is closed and the wall shortens without causing spring-back tension.
  • the ventilation interface system can provide the ventilation gas from the ventilation source to the nares at a lower velocity as compared to the conventional ventilation interface, thereby decreasing an amount of moisture removed from the mucosal walls. Further the ventilation interface system provides better comfort and functionality over the known conventional systems. Numerous additional modifications and variations of the exemplary embodiments present invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims, exemplary embodiments of the present invention may be practiced otherwise than as specifically described herein.

Abstract

Cette invention concerne un système d'interface de ventilation ou de ventilation spontanée en pression positive continue (CPAP) conçu pour être introduit dans les narines d'un utilisateur afin de fixer l'interface. Une canule conçue pour être reliée à une source de gaz de ventilation constitue une première partie d'un passage de circulation de gaz d'admission permettant de fournir le gaz de ventilation à l'utilisateur. Un élément d'insertion nasal conçu pour être introduit dans les narines de l'utilisateur constitue une seconde partie du passage de circulation de gaz d'admission de la canule à une extrémité distale de l'élément d'insertion nasal. Une partie d'étanchéité conçue pour être au contact d'une partie de la première narine est disposée à proximité de l'extrémité distale de l'élément d'insertion nasal. Le système d'interface de ventilation peut éventuellement comprendre des tubes d'alimentation, un raccord en y, un porte-tubes et un casque.
PCT/US2003/024590 2003-08-06 2003-08-06 Interface nasale et systeme comprenant un element d'insertion de ventilation WO2005016425A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2003258103A AU2003258103A1 (en) 2003-08-06 2003-08-06 Nasal interface and system including ventilation insert
PCT/US2003/024590 WO2005016425A1 (fr) 2003-08-06 2003-08-06 Interface nasale et systeme comprenant un element d'insertion de ventilation
US10/876,480 US7000613B2 (en) 2003-08-06 2004-06-28 Nasal interface and system including ventilation insert
US10/880,521 US7472707B2 (en) 2003-08-06 2004-07-01 Nasal interface and system including ventilation insert

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/024590 WO2005016425A1 (fr) 2003-08-06 2003-08-06 Interface nasale et systeme comprenant un element d'insertion de ventilation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/880,521 Continuation US7472707B2 (en) 2003-08-06 2004-07-01 Nasal interface and system including ventilation insert

Publications (1)

Publication Number Publication Date
WO2005016425A1 true WO2005016425A1 (fr) 2005-02-24

Family

ID=34192553

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/024590 WO2005016425A1 (fr) 2003-08-06 2003-08-06 Interface nasale et systeme comprenant un element d'insertion de ventilation

Country Status (2)

Country Link
AU (1) AU2003258103A1 (fr)
WO (1) WO2005016425A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012761B2 (en) 2006-12-14 2011-09-06 Kimberly-Clark Worldwide, Inc. Detection of formaldehyde in urine samples
CN108714266A (zh) * 2007-10-22 2018-10-30 瑞思迈有限公司 患者接口系统
GB2575050A (en) * 2018-06-26 2020-01-01 Draeger Safety Uk Ltd Connection apparatus for breathing apparatus

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US853439A (en) * 1903-10-14 1907-05-14 Albert C Clark Inhaler.
US4782832A (en) * 1987-07-30 1988-11-08 Puritan-Bennett Corporation Nasal puff with adjustable sealing means
US4919128A (en) * 1988-08-26 1990-04-24 University Technologies International Inc. Nasal adaptor device and seal
US5477852A (en) * 1991-10-29 1995-12-26 Airways Ltd., Inc. Nasal positive airway pressure apparatus and method
US5687715A (en) * 1991-10-29 1997-11-18 Airways Ltd Inc Nasal positive airway pressure apparatus and method
US6422240B1 (en) * 1998-01-29 2002-07-23 Oridion Medical Ltd. Oral/nasal cannula
US6431172B1 (en) * 2000-10-20 2002-08-13 Mallinckrodt Inc. Nasal cannula with inflatable plenum chamber
US20030079749A1 (en) * 2001-10-25 2003-05-01 Roger Strickland Nasal cannula

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US853439A (en) * 1903-10-14 1907-05-14 Albert C Clark Inhaler.
US4782832A (en) * 1987-07-30 1988-11-08 Puritan-Bennett Corporation Nasal puff with adjustable sealing means
US4919128A (en) * 1988-08-26 1990-04-24 University Technologies International Inc. Nasal adaptor device and seal
US5477852A (en) * 1991-10-29 1995-12-26 Airways Ltd., Inc. Nasal positive airway pressure apparatus and method
US5687715A (en) * 1991-10-29 1997-11-18 Airways Ltd Inc Nasal positive airway pressure apparatus and method
US6422240B1 (en) * 1998-01-29 2002-07-23 Oridion Medical Ltd. Oral/nasal cannula
US6431172B1 (en) * 2000-10-20 2002-08-13 Mallinckrodt Inc. Nasal cannula with inflatable plenum chamber
US20030079749A1 (en) * 2001-10-25 2003-05-01 Roger Strickland Nasal cannula

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012761B2 (en) 2006-12-14 2011-09-06 Kimberly-Clark Worldwide, Inc. Detection of formaldehyde in urine samples
CN108714266A (zh) * 2007-10-22 2018-10-30 瑞思迈有限公司 患者接口系统
GB2575050A (en) * 2018-06-26 2020-01-01 Draeger Safety Uk Ltd Connection apparatus for breathing apparatus
GB2575050B (en) * 2018-06-26 2022-09-14 Draeger Safety Uk Ltd Connection apparatus for breathing apparatus

Also Published As

Publication number Publication date
AU2003258103A1 (en) 2005-03-07

Similar Documents

Publication Publication Date Title
US6997187B2 (en) Nasal interface and system including ventilation insert
US7000613B2 (en) Nasal interface and system including ventilation insert
US7472707B2 (en) Nasal interface and system including ventilation insert
US7234465B2 (en) Nasal ventilation interface and system
US20050252515A1 (en) Nasal interface including ventilation insert
US7191781B2 (en) Nasal ventilation interface and system
US9919121B2 (en) Ventilation interface for sleep apnea therapy
US7845352B2 (en) Flexible CPAP mask
US20050121037A1 (en) Nasal ventilation interface
US7353826B2 (en) Sealing nasal cannula
US6595215B2 (en) Ventilation interface for sleep apnea therapy
US20050235999A1 (en) Nasal ventilation interface and system
US6776162B2 (en) Ventilation interface for sleep apnea therapy
US20060107958A1 (en) Adjustable sealing nasal cannula
WO2005016425A1 (fr) Interface nasale et systeme comprenant un element d'insertion de ventilation
CA2368825C (fr) Interface de ventilation servant au traitement de l'apnee du sommeil

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 10880521

Country of ref document: US

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: COMMUNICATION PURSUANT TO RULE 69(1) EPC (FORM 1205A) SENT 17.05.2006.

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP